본문 바로가기
KERD
논문KCI 등재

Impact of mesenchymal stem cell senescence on inflammaging

Byung-Chul Lee|유경록
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2020.02|BMB Reports|제53권 제2호|pp. 65-73

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

Mesenchymal stem cellsImmunosenescenceInflammagingMSC nicheSenescence-associated secretory phenotype (SASP
주제분류화학

초록

Life expectancy has dramatically increased around the world over the last few decades, and staying healthier longer, without chronic disease, has become an important issue. Although understanding aging is a grand challenge, our understanding of the mechanisms underlying the degeneration of cell and tissue functions with age and its contribution to chronic disease has greatly advanced during the past decade. As our immune system alters with aging, abnormal activation of immune cells leads to imbalance of innate and adaptive immunity and develops a persistent and mild systemic inflammation, inflammaging. With their unique therapeutic properties, such as immunomodulation and tissue regeneration, mesenchymal stem cells (MSCs) have been considered to be a promising source for treating autoimmune disease or as anti-aging therapy. Although direct evidence of the role of MSCs in inflammaging has not been thoroughly studied, features reported in senescent MSCs or the aging process of MSCs are associated with inflammaging; MSC niche-driven skewing of hematopoiesis toward the myeloid lineage or oncogenesis, production of pro-inflammatory cytokines, and weakening their modulative property on macrophage polarization, which plays a central role on inflammaging development. This review explores the role of senescent MSCs as an important regulator for onset and progression of inflammaging and as an effective target for anti-aging strategies.

Abstract

Life expectancy has dramatically increased around the world over the last few decades, and staying healthier longer, without chronic disease, has become an important issue. Although understanding aging is a grand challenge, our understanding of the mechanisms underlying the degeneration of cell and tissue functions with age and its contribution to chronic disease has greatly advanced during the past decade. As our immune system alters with aging, abnormal activation of immune cells leads to imbalance of innate and adaptive immunity and develops a persistent and mild systemic inflammation, inflammaging. With their unique therapeutic properties, such as immunomodulation and tissue regeneration, mesenchymal stem cells (MSCs) have been considered to be a promising source for treating autoimmune disease or as anti-aging therapy. Although direct evidence of the role of MSCs in inflammaging has not been thoroughly studied, features reported in senescent MSCs or the aging process of MSCs are associated with inflammaging; MSC niche-driven skewing of hematopoiesis toward the myeloid lineage or oncogenesis, production of pro-inflammatory cytokines, and weakening their modulative property on macrophage polarization, which plays a central role on inflammaging development. This review explores the role of senescent MSCs as an important regulator for onset and progression of inflammaging and as an effective target for anti-aging strategies.

참고문헌 (98)

  1. Kontis V, "Future life expectancy in 35 industrialised countries : projections with a Bayesian model ensemble", Lancet, 389, pp.1323~1335 (2017)
  2. Franceschi C, "Immunobiography and the Heterogeneity of Immune Responses in the Elderly : A Focus on Inflammaging and Trained Immunity", Front Immunol, 8, pp.982~ (2017)
  3. Fulop T, "Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?", Front Immunol 8, 8, pp.1960~ (2017)
  4. Yu KR, "The impact of aging on primate hematopoiesis as interrogated by clonal tracking", Blood, 131, pp.1195~1205 (2018)
  5. Pang WW, "Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age", Proc Natl Acad Sci U S A, 108, pp.20012~20017 (2011)
  6. Derhovanessian E, "Hallmark features of immunosenescence are absent in familial longevity", J Immunol, 185, pp.4618~4624 (2010)
  7. Smolen JS, "Rheumatoid arthritis", Lancet, 388, pp.2023~2038 (2016)
  8. Libby P, "Inflammation and atherosclerosis", Circulation, 105, pp.1135~1143 (2002)
  9. Heppner FL, "Immune attack : the role of inflammation in Alzheimer disease", Nat Rev Neurosci, 16, pp.358~372 (2015)
  10. Franceschi C, "Inflammaging. An evolutionary perspective on immunosenescence", Ann N Y Acad Sci, 908, pp.244~254 (2000)
  11. Fransen F, "Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice", Front Immunol, 8, pp.1385~ (2017)
  12. Calcada D, "The role of low-grade inflammation and metabolic flexibility in aging and nutritional modulation thereof : a systems biology approach", Mech Ageing Dev, 136-137, pp.138~147 (2014)
  13. Yu KR, "Aging-related genes in mesenchymal stem cells : a mini-review", Gerontology, 59, pp.557~563 (2013)
  14. Yu KR, "A p38 MAPK-mediated alteration of COX-2", PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging, 2014, pp.9, e102426~
  15. Badiavas AR, "Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing", Expert Opin Biol Ther, 11, pp.1447~1454 (2011)
  16. Wagner W, "Replicative senescence of mesenchymal stem cells : a continuous and organized process", PLoS One, 3, pp.e2213~ (2008)
  17. Yang YM, "Effect of aged bone marrow microenvironment on mesenchymal stem cell migration", Age (Dordr), 37, pp.16~ (2015)
  18. Franceschi C, "Inflammaging and 'Garb-aging'", Trends Endocrinol Metab, 28, pp.199~212 (2017)
  19. Franceschi C, "Chronic inflammation(inflammaging)and its potential contribution to ageassociated diseases", J Gerontol A Biol Sci Med Sci 69Suppl, 69(Suppl 1), pp.S4~S9 (2014)
  20. Robbins PD, "Extracellular vesicles and aging", Stem Cell Investig, 4, pp.98~ (2017)
  21. Agarwal S, "Innate and adaptive immunosenescence", Ann Allergy Asthma Immunol, 104, pp.183~190 (2010)
  22. Franceschi C, "Inflammaging : a new immune-metabolic viewpoint for age-related diseases", Nat Rev Endocrinol, 14, pp.576~ (2018)
  23. Frasca D, "Inflammaging decreases adaptive and innate immune responses in mice and humans", Biogerontology, 17, pp.7~19 (2016)
  24. Martucci M, "Mediterranean diet and inflammaging within the hormesis paradigm", Nutr Rev, 75, pp.442~455 (2017)
  25. Szarc vel Szic K, "From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?", Clin Epigenetics, 7, pp.33~ (2015)
  26. 강주빈, "Lipopolysaccharide induces neuroglia activation and NF-κB activation in cerebral cortex of adult mice", Laboratory Animal Research, 35(3), pp.132~139 (2019), 한국실험동물학회[DOI]
  27. Salminen A, "Activation of innate immunity system during aging : NF-kB signaling is the molecular culprit of inflamm-aging", Ageing Res Rev, 7, pp.83~105 (2008)
  28. Chazaud B, "Inflamm-aging : STAT3 signaling pushes muscle stem cells off balance", Cell Stem Cell, 15, pp.401~402 (2014)
  29. Latz E, "NLRP3 inflammasome activation in inflammaging", Semin Immunol, 40, pp.61~73 (2018)
  30. Salminen A, "Inflammaging : disturbed interplay between autophagy and inflammasomes", Aging (Albany NY), 4, pp.166~175 (2012)
  31. Steele AK, "Contribution of intestinal barrier damage, microbial translocation and HIV-1 infection status to an inflammaging signature", PLoS One, 9, pp.e97171~ (2014)
  32. 강인선, "Donor-dependent variation of human umbilical cord blood mesenchymal stem cells in response to hypoxic preconditioning and amelioration of limb ischemia", Experimental and Molecular Medicine, 50, pp.1~15 (2018), 생화학분자생물학회
  33. Lee BC, "Disease-specific primed human adult stem cells effectively ameliorate experimental atopic dermatitis in mice", Theranostics, 9, pp.3608~3621 (2019)
  34. Katakowski M, "Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth", Cancer Lett, 335, pp.201~204 (2013)
  35. Lai RC, "Exosome secreted by MSC reduces myocardial ischemia", reperfusion injury, 2010, pp.4, 214~222
  36. de Witte SFH, "Immunomodulation By Therapeutic Mesenchymal Stromal Cells(MSC)Is Triggered Through Phagocytosis of MSC By Monocytic Cells", Stem Cells, 36, pp.602~615 (2018)
  37. Bonab MM, "Aging of mesenchymal stem cell in vitro", BMC Cell Biol, 7, pp.14~ (2006)
  38. Li Y, "Senescence of mesenchymal stem cells(Review)", Int J Mol Med, 39, pp.775~782 (2017)
  39. Ramasamy R, "Advanced glycation end products and RAGE : a common thread in aging, diabetes, neurodegeneration, and inflammation", Glycobiology, 15, pp.16R~28R (2005)
  40. Pisetsky DS, "High-mobility group box protein 1(HMGB1) : an alarmin mediating the pathogenesis of rheumatic disease", Arthritis Res Ther, 10, pp.209~ (2008)
  41. Salminen A, "Mitochondrial dysfunction and oxidative stress activate inflammasomes : impact on the aging process and age-related diseases", Cell Mol Life Sci, 69, pp.2999~3013 (2012)
  42. Yeo RW, "Mesenchymal stem cell : an efficient mass producer of exosomes for drug delivery", Adv Drug Deliv Rev, 65, pp.336~341 (2013)
  43. Mokarizadeh A, "Microvesicles derived from mesenchymal stem cells : potent organelles for induction of tolerogenic signaling", Immunol Lett, 147, pp.47~54 (2012)
  44. Lei Q, "Microvesicles as Potential Biomarkers for the Identification of Senescence in Human Mesenchymal Stem Cells", Theranostics, 7, pp.2673~2689 (2017)
  45. Lehmann BD, "Senescence-associated exosome release from human prostate cancer cells", Cancer Res, 68, pp.7864~7871 (2008)
  46. Burger D, "Microparticles induce cell cycle arrest through redoxsensitive processes in endothelial cells : implications in vascular senescence", J Am Heart Assoc, 1, pp.e001842~ (2012)
  47. Peffers MJ, "Age-related changes in mesenchymal stem cells identified using a multi-omics approach", Eur Cell Mater, 31, pp.136~159 (2016)
  48. Fleshner M, "Exosomes, DAMPs and miRNA : Features of Stress Physiology and Immune Homeostasis", Trends Immunol, 38, pp.768~776 (2017)
  49. Balasubramanyam M, "Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes", Mol Cell Biochem, 351, pp.197~205 (2011)
  50. de Haan G, "Aging of hematopoietic stem cells", Blood, 131, pp.479~487 (2018)
  51. Pang WW, "Age-associated changes in human hematopoietic stem cells", Semin Hematol, 54, pp.39~42 (2017)
  52. Minciullo PL, "Inflammaging and Anti-Inflammaging : The Role of Cytokines in Extreme Longevity", Arch Immunol Ther Exp (Warsz), 64, pp.111~126 (2016)
  53. Coppe JP, "The senescence-associated secretory phenotype : the dark side of tumor suppression", Annu Rev Pathol, 5, pp.99~118 (2010)
  54. Mattiucci D, "Aging-and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes", Cell Transplant, 27, pp.754~764 (2018)
  55. Bonafe M, "Inflamm-aging of the stem cell niche : breast cancer as a paradigmatic example : breakdown of the multi-shell cytokine network fuels cancer in aged people", Bioessays, 34, pp.40~49 (2012)
  56. Lepperdinger G, "Inflammation and mesenchymal stem cell aging", Curr Opin Immunol, 23, pp.518~524 (2011)
  57. Cartwright MJ, "Aging in adipocytes : potential impact of inherent, depot-specific mechanisms", Exp Gerontol, 42, pp.463~471 (2007)
  58. Starr ME, "Age-associated increase in cytokine production during systemic inflammation : adipose tissue as a major source of IL-6", J Gerontol A Biol Sci Med Sci, 64, pp.723~730 (2009)
  59. Romieu-Mourez R, "Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype", J Immunol, 182, pp.7963~7973 (2009)
  60. Di GH, "IL-6secreted from senescent mesenchymal stem cells promotes proliferation and migration of breast cancer cells", PLoS One, 9, pp.e113572~ (2014)
  61. O'Hagan-Wong K, "Increased IL-6 secretion by aged human mesenchymal stromal cells disrupts hematopoietic stem and progenitor cells' homeostasis", Oncotarget, 7, pp.13285~13296 (2016)
  62. Carvalho JL, "Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction", J Cell Mol Med, 17, pp.617~625 (2013)
  63. Balandran JC, "Proinflammatory-Related Loss of CXCL12 Niche Promotes Acute Lymphoblastic Leukemic Progression at the Expense of Normal Lymphopoiesis", Front Immunol, 7, pp.666~ (2016)
  64. Oishi Y, "Macrophages in age-related chronic inflammatory diseases", NPJ Aging Mech Dis, 2, pp.16018~ (2016)
  65. Shin TH, "Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis", Cell Death Dis, 7, pp.e2524~ (2016)
  66. Pajarinen J, "Mesenchymal stem cell-macrophage crosstalk and bone healing", Biomaterials, 196, pp.80~89 (2019)
  67. Yin Y, "Influences of age-related changes in mesenchymal stem cells on macrophages during in-vitro culture", Stem Cell Res Ther, 8, pp.153~ (2017)
  68. Kovtonyuk LV, "Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment", Front Immunol, 7, pp.502~ (2016)
  69. Shepherd MS, "Emerging single-cell tools are primed to reveal functional and molecular heterogeneity in malignant hematopoietic stem cells", Curr Opin Hematol, 26, pp.214~221 (2019)
  70. Wilson NK, "Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations", Cell Stem Cell, 16, pp.712~724 (2015)
  71. Chen Z, "Cohesin-mediated NF-kappaB signaling limits hematopoietic stem cell self-renewal in aging and inflammation", J Exp Med, 216, pp.152~175 (2019)
  72. Geiger H, "Hematopoietic stem cell aging", Curr Opin Immunol, 29, pp.86~92 (2014)
  73. Linehan E, "Aging impairs peritoneal but not bone marrow-derived macrophage phagocytosis", Aging Cell, 13, pp.699~708 (2014)
  74. Lloberas J, "Effect of aging on macrophage function", Exp Gerontol, 37, pp.1325~1331 (2002)
  75. Lim Z, "Allogeneic hematopoietic stem-cell transplantation for patients 50years or older with myelodysplastic syndromes or secondary acute myeloid leukemia", J Clin Oncol, 28, pp.405~411 (2010)
  76. Gibson KL, "B-cell diversity decreases in old age and is correlated with poor health status", Aging Cell, 8, pp.18~25 (2009)
  77. Castilho JL, "CD4+", CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy, 2016, pp.30, 899~908
  78. Ghajar CM, "The perivascular niche regulates breast tumour dormancy", Nat Cell Biol, 15, pp.807~817 (2013)
  79. Zambetti NA, "Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia", Cell Stem Cell, 19, pp.613~627 (2016)
  80. Kim M, "Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential : implication to age-associated bone diseases and defects", Mech Ageing Dev, 133, pp.215~225 (2012)
  81. Justesen J, "Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis", Biogerontology, 2, pp.165~171 (2001)
  82. Ambrosi TH, "Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration", Cell Stem Cell, 20, pp.771~784 e776 (2017)
  83. Baker N, "Characterization of bone marrow-derived mesenchymal stem cells in aging", Bone, 70, pp.37~47 (2015)
  84. Bilwani FA, "Adipocyte-derived soluble factor(s)inhibits early stages of B lymphopoiesis", J Immunol, 189, pp.4379~4386 (2012)
  85. Ergen AV, "Rantes", Ccl5influences hematopoietic stem cell subtypes and causes myeloid skewing, 2012, pp.119, 2500~2509
  86. Busque L, "Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis", Nat Genet, 44, pp.1179~1181 (2012)
  87. Inoue S, "Roles of IDH1", 2 and TET2 mutations in myeloid disorders, 2016, pp.103, 627~633
  88. Suijker J, "The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or-2 blocks osteoblast differentiation in vitro and in vivo", Oncotarget, 6, pp.14832~14842 (2015)
  89. Valli A, "Hypoxia metabolism in ageing", Aging (Albany NY), 7, pp.465~466 (2015)
  90. Intlekofer AM, "Hypoxia Induces Production of L-2-Hydroxyglutarate", Cell Metab, 22, pp.304~311 (2015)
  91. Cicione C, "Effects of severe hypoxia on bone marrow mesenchymal stem cells differentiation potential", Stem Cells Int, 2013, pp.232896~ (2013)
  92. Xing J, "Hypoxia induces senescence of bone marrow mesenchymal stem cells via altered gut microbiota", Nat Commun, 9, pp.2020~ (2018)
  93. Abdel-Wahab O, "ASXL1mutations promote myeloid transformation through loss of PRC2-mediated gene repression", Cancer Cell, 22, pp.180~193 (2012)
  94. Rohatgi N, "ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1", Blood Adv, 2, pp.2467~2477 (2018)
  95. Uni M, "Modeling ASXL1mutation revealed impaired hematopoiesis caused by derepression of p16Ink4a through aberrant PRC1-mediated histone modification", Leukemia, 33, pp.191~204 (2019)
  96. Zhang P, "Loss of ASXL1 in the bone marrow niche dysregulates hematopoietic stem and progenitor cell fates", Cell Discov, 4, pp.4~ (2018)
  97. Sun X, "Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats", Stem Cell Res Ther, 8, pp.241~ (2017)
  98. Turinetto V, "Senescence in Human Mesenchymal Stem Cells : Functional Changes and Implications in Stem Cell-Based Therapy", Int J Mol Sci, 17, pp.1164~ (2016)

관련 논문AI추천

Systemic aging delay and anti-aging therapy using allogeneic stem cellsSeongho Han, Sung-Whan Kim대한가정의학회 · Korean Journal of Family Medicine2025 · 제46권 제3호Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical ReviewDominique Bron, Laurence Lagneaux, Mehdi Najar, Mohammad Krayem, Nathalie Meuleman대한면역학회 · Immune Network2017 · 제17권 제2호Targeting immunosenescence and inflammaging: advancing longevity researchCho Kyung A, Nguyen Thi Quynh Trang생화학분자생물학회 · Experimental and Molecular Medicine2025 · 제57권 Usage of Human Mesenchymal Stem Cells in Cell-based Therapy: Advantages and Disadvantages김희정, 박정수한국발생생물학회 · 발생과 생식2017 · 제21권 제1호From cell senescence to age-related diseases: differential mechanisms of action of senescence-associated secretory phenotypes김정민, 변해옥, 윤계순, 이영경생화학분자생물학회 · BMB Reports2015 · 제48권 제10호Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment이윤주, 임경민, 조쌍구, 아브달아메드, Arthi Kirubhakaran, Balachandar Vellingiri, Iyer Mahalaxmi, Jong Yub An, Kaavya Jayaramayya, Mohana Devi Subramaniam, Neethu Raj, Se Jong Kim, Yujin Choi생화학분자생물학회 · BMB Reports2020 · 제53권 제8호

이 간행물의 다른 논문 (8건)

Traction Force Microscopy for Understanding Cellular Mechanotransduction박재홍, 정지훈, 윤정교, 반명진, 허성식, Yongsung Hwangpp. 74-81Circular RNA hsa_circ_0075828 Promotes Bladder Cancer Cell Proliferation Through Activation of CREB1Chengle Zhuang, Yaoting Gui, Xinbo Huang, Jing Yupp. 82-87Overcoming Multidrug Resistance by Activating Unfolded Protein Response of the Endoplasmic Reticulum in Cisplatin-Resistant A2780/CisR Ovarian Cancer Cells고동수, 신순영, 이영한, YOONGHO LIM, 정의택pp. 88-93Functional Analysis of RNA Motifs Essential for BC200 RNA-mediated Translational Regulation이영훈, 신희권, 장성희pp. 94-99Heterogeneity in Liver Histopathology Is Associated With GSK-3β Activity and Mitochondrial Dysfunction in End-Stage Diabetic Rats on Differential Diets이주한, 김성영, 노연희, 최수봉, 유정수, 한상돈, 임인자, 이준호, 성동준, Ming Li Jin, Ji Young Mun, 황태숙, Young-Tae Ropp. 100-105
원문 보기